Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07659743 · ClinicalTrials.gov registry record · NA
BreEStim in Managing Neuropathic Pain After Spinal Cord Injury (SCI)
A NA study, sponsored by The University of Texas Health Science Center, Houston.
- Not yet
- Registry status
- NA
- Development phase
- 66
- Enrollment target
NCT07659743 is a NA study that has not yet begun recruiting, run by The University of Texas Health Science Center, Houston. The registered enrollment target is 66 participants.
The verdict
NCT07659743, a NA study, has not yet begun recruiting, sponsored by The University of Texas Health Science Center, Houston.
- NOT YET RECRUITING
- Registry status
- NA
- Development phase
- 66 participants
- Enrollment target
Study Summary
The purpose of this study is to compare the effectiveness of innovative intervention of breathing controlled electrical stimulation (BreEStim) and sham BreEStim and Transcutaneous Electrical Nerve Stimulation (TENS) in management of neuropathic pain in patients after spinal cord injury (SCI).
Interventions
- DEVICE Active BreEStim Treatment
- DEVICE Sham BreEStim Treatment
- DEVICE The TENS Treatment
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 66 participants |
| Start Date | 2026-10-01 |
| Est. Completion | 2029-09-30 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07659743
The ClinicalTrials.gov registry entry for NCT07659743 describes a study currently listed as not yet recruiting, categorized as NA. The registered enrollment target is 66 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is The University of Texas Health Science Center, Houston, which has 732 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Active BreEStim Treatment is the first listed.
NCT07659743 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT07659743 about?
NCT07659743 is a clinical study titled "BreEStim in Managing Neuropathic Pain After Spinal Cord Injury (SCI)". The purpose of this study is to compare the effectiveness of innovative intervention of breathing controlled electrical stimulation (BreEStim) and sham BreEStim and Transcutaneous Electrical Nerve Stimulation (TENS) in management of neuropathic pain in patients after spinal cord injury (SCI).
What is the current status of trial NCT07659743?
This trial is currently not yet recruiting. It is a NA study. The enrollment target is 66 participants. The study started on 2026-10-01. Estimated completion is 2029-09-30.
What interventions are being tested in trial NCT07659743?
The interventions under investigation include: Active BreEStim Treatment (DEVICE), Sham BreEStim Treatment (DEVICE), The TENS Treatment (DEVICE).
Who is sponsoring clinical trial NCT07659743?
This trial is sponsored by The University of Texas Health Science Center, Houston, which has 732 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.